查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1916925

非PVC輸液袋市場按產品類型、包裝、容器尺寸、流速、應用、最終用戶和分銷管道分類－2026年至2032年全球預測

Non-PVC IV Fluid Bags Market by Product Type, Packaging, Container Size, Flow Rate, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，非 PVC 輸液袋市場價值將達到 18.9 億美元，到 2026 年將成長至 20.4 億美元，到 2032 年將達到 35.3 億美元，複合年成長率為 9.30%。

主要市場統計數據
基準年 2025 18.9億美元
預計年份：2026年 20.4億美元
預測年份：2032年 35.3億美元
複合年成長率 (%) 9.30%

非PVC輸液袋全面介紹：識別影響其應用的臨床因素、替代材料和採購趨勢

非PVC輸液袋市場正在經歷一場變革，這場變革融合了臨床安全需求、採購流程最佳化和永續性三大優先事項。臨床醫師和供應鏈管理者越來越重視那些能夠消除PVC相關塑化劑和潛在萃取物，同時保持無菌性、輸液相容性和操作特性的材料。這種轉變正推動供應商實現膠體和晶體配方的多樣化。膠體包括白蛋白、聚葡萄糖、明膠和羥乙基澱粉，而晶體則與平衡溶液、葡萄糖、生理食鹽水水和乳酸林格氏液相容，所有這些溶液都與非PVC聚合物基質相容。

監管壓力、材料創新、永續性措施和分銷模式轉變等關鍵變革力量正在重塑非PVC輸液袋。

非PVC輸液袋市場格局正經歷變革性變化，其根源在於監管壓力、材料科學的進步以及採購優先事項的轉變。對塑化劑和萃取物的監管力度加大，加速了替代聚合物和製造程序的採用，這些替代聚合物和工藝在提供同等阻隔性和無菌性能的同時，避免了傳統的健康隱患。同時，醫療系統和支付方的永續性措施越來越關注產品的全生命週期影響，要求企業評估其回收性、能源消耗和報廢處理方法。反過來，這也影響著原料的選擇和供應鏈的設計。

評估2025年美國關稅對非PVC輸液袋生態系統的供應鏈、籌資策略和製造因應措施的累積影響

2025年美國關稅政策對採購、成本結構和策略採購產生了累積影響，波及整個非PVC輸液袋價值鏈。依賴海外供應商的企業面臨聚合物樹脂、成品容器和關鍵零件進口成本上升的困境，迫使買家和製造商重新評估供應商多元化策略，並加快對替代供應來源的資格認證。因此，近岸外包和本地契約製造等方案正日益受到重視，成為在維持供應連續性的同時降低關稅風險的有效途徑。

將產品配方、臨床應用、最終用戶、包裝形式、容器尺寸和流動模式與商業策略聯繫起來的可操作細分洞察

按產品類型分類，膠體產品和晶體產品在技術和商業性特性方面有顯著差異。膠體產品，包括白蛋白、聚葡萄糖、明膠和羥乙基澱粉，需要仔細考慮蛋白質穩定性、滲透效應以及與容器材料的相互作用。而晶體產品，例如平衡溶液、葡萄糖、生理食鹽水水和乳酸林格氏液，則更注重電解質的精確性和長期儲存所需的容器相容性。這些配方差異決定了保存期限測試、相容性測試方案和臨床定位策略，同時也推動了供應商在更廣泛的材料細分領域內的專業化發展。

美洲、歐洲、中東和非洲以及亞太地區的區域競爭和應用趨勢將影響監管方法、供應模式和臨床應用。

區域趨勢正在影響美洲、歐洲、中東和非洲以及亞太地區的市場採納管道和競爭格局，每個地區都展現出獨特的法規結構、採購實踐和臨床偏好。在美洲，大規模綜合醫療保健系統和中央採購機構優先考慮監管的清晰度、供應商的可靠性和營運成本控制，從而推動了對具有成熟安全資格和供應鏈透明度的材料的需求。服務該地區的製造商必須擁有健全的品質系統和在合理前置作業時間內實現規模化生產的能力。

企業策略概況強調材料創新、卓越製造、通路夥伴關係以及臨床證據的生成，以塑造競爭優勢。

非PVC輸液袋市場的企業層面發展趨勢日益受到技術差異化、製造地擴張和策略聯盟的影響。主要企業正加大對聚合物科學、相容性測試和多腔設計等領域的投入，以拓展產品系列，滿足不同臨床應用的細微需求。與輸液設備製造商和臨床研究夥伴的策略合作，也有助於強化產品提案，並促進真實世界證據的生成，從而支持藥物目錄的收錄和臨床應用。

為製造商和供應鏈領導者提供切實可行的、優先排序的策略建議，以加快技術應用、降低關稅風險並加強臨床夥伴關係。

產業領導者應採取協調一致的策略，整合材料創新、供應鏈韌性和臨床合作，以加速非PVC輸液解決方案的推廣應用。首先，應優先投資於聚合物研究和相容性測試，以確保其在膠體和晶體製劑方面均能達到與傳統PVC系統相當的性能，從而減少臨床醫生和採購團隊面臨的障礙。同時，應擴大多腔技術和容器尺寸的檢驗項目，以滿足急診護理、門診護理和家庭輸液的不同需求。

我們以透明的方式解釋了為檢驗我們的關鍵發現和細分市場層面的結論而採用的一手和二手調查方法、相關人員訪談以及三角驗證技術。

本分析的調查方法結合了與關鍵相關人員的初步研究和嚴格的二次檢驗，以確保獲得可靠且可操作的洞見。初步研究包括對醫院、門診手術中心和居家醫療機構的採購主管進行結構化訪談，以及與代表醫院藥房、線上藥房和批發商的分銷管道主管進行討論。這些對話提供了關於採購標準、處理偏好以及過渡到非PVC系統對營運影響的第一手資訊。

本文對推動向非PVC輸液袋過渡的利害關係人的策略意義、推廣促進因素和實際優先事項進行了重要的綜合分析，並提出了相關建議。

向非PVC輸液袋的過渡是一項具有重要戰略意義的變革，其驅動力源於安全考量、監管要求以及新興的永續性優先事項。材料創新和包裝設計進步降低了技術壁壘，使其能夠更廣泛地應用於膠體和晶體療法，滿足從醫院到居家醫療機構等不同終端用戶的需求。分銷管道在推廣應用方面發揮核心作用，醫院藥房、批發商和線上藥房各自影響產品的獲取途徑、合約條款以及終端用戶培訓要求。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 非PVC輸液袋市場（依產品類型分類）

  • 膠體製劑
    • 白蛋白
    • 聚葡萄糖
    • 明膠
    • 羥乙基澱粉
  • 晶體溶液
    • 平衡液體
    • 葡萄糖
    • 生理食鹽水
    • 林格氏乳酸鹽溶液

9. 非PVC輸液袋市場（依包裝類型分類）

  • 多腔袋
    • 雙腔體
    • 三腔體
  • 單室袋

第10章 依容器尺寸分類的非PVC輸液袋市場

  • 250～500ml
  • 500～1,000ml
  • 1000毫升或更多
  • 250毫升或以下

11.按流速分類的非PVC輸液袋市場

  • 重力型
  • 點滴幫浦

第12章 非PVC輸液袋市場依應用領域分類

  • 血液容積補充
  • 注射毒品
  • 電解質補充
  • 營養補充

第13章 非PVC輸液袋市場（依最終用戶分類）

  • 門診手術中心
  • 診所
  • 居家醫療保健服務提供者
  • 醫院

第14章 非PVC輸液袋市場（依通路分類）

  • 醫院藥房
  • 網路藥房
  • 批發商

15. 非PVC輸液袋市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 非PVC輸液袋市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國非PVC輸液袋市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章美國非PVC輸液袋市場

第17章：中國非PVC輸液袋市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Angiplast Pvt. Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Haemotronic SpA
  • ICU Medical, Inc.
  • JW Life Science Corp.
  • Kraton Corporation
  • Medline Industries, LP
  • Nipro Corporation
  • Otsuka Pharmaceutical Factory, Inc.
  • PolyCine GmbH
  • RENOLIT SE
  • Sippex IV bags
  • Technoflex SAS
Product Code: MRR-AE420CB153FB

The Non-PVC IV Fluid Bags Market was valued at USD 1.89 billion in 2025 and is projected to grow to USD 2.04 billion in 2026, with a CAGR of 9.30%, reaching USD 3.53 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.89 billion
Estimated Year [2026] USD 2.04 billion
Forecast Year [2032] USD 3.53 billion
CAGR (%) 9.30%

An encompassing introduction to non-PVC intravenous fluid bags that clarifies clinical drivers, material alternatives, and procurement dynamics shaping adoption

The non-PVC intravenous fluid bags landscape is evolving at the intersection of clinical safety imperatives, procurement rationalization, and sustainability priorities. Clinicians and supply chain leaders are increasingly prioritizing materials that eliminate PVC-related plasticizers and potential leachables while preserving sterility, fluid compatibility, and handling characteristics. This shift has encouraged suppliers to diversify across colloids and crystalloids formulations, with colloids including albumin, dextran, gelatins, and hydroxyethyl starch and crystalloids spanning balanced solutions, dextrose, normal saline, and Ringer's lactate, all adapted to non-PVC polymer matrices.

End-use environments shape product requirements, as hospitals demand high-volume, standardized containers for acute care while ambulatory surgical centers and clinics emphasize convenience and shelf-stable formats. Home healthcare providers seek packaging that supports safe administration outside institutional settings, and distribution channels ranging from hospital pharmacies to online pharmacies and wholesale distributors determine lead times and stocking strategies. Packaging design is also central; single chamber and multi chamber formats, with dual and triple chamber options, cater to complex therapies and combined delivery regimens. Container sizing requirements vary across clinical settings and procedural needs, from small volume units to larger bags, while flow modalities such as gravity flow and infusion pumps introduce compatibility and regulatory testing considerations.

In sum, non-PVC IV fluid bags must balance material innovation, clinical performance, and supply chain robustness to meet diverse applications, end users, and distribution models. This report introduces these dynamics and frames the consequential operational and strategic decisions facing manufacturers, healthcare providers, and distributors

Critical transformative forces reshaping non-PVC IV fluid bags driven by regulatory pressure, material innovation, sustainability commitments, and changing distribution paradigms

The landscape for non-PVC IV fluid bags is undergoing transformative shifts rooted in regulatory pressure, material science advances, and changing procurement priorities. Regulatory scrutiny over plasticizers and leachables has accelerated adoption of alternative polymers and manufacturing processes designed to deliver comparable barrier and sterility performance without legacy health concerns. Concurrently, sustainability commitments from health systems and payers are elevating lifecycle impacts, prompting firms to evaluate recyclability, energy intensity, and end-of-life handling, which in turn influence raw material choices and supply chain design.

Material innovation has been matched by functional evolution in product architecture. The development of reliable multi chamber systems-both dual and triple chamber configurations-enables pre-mixed therapies and enhances operational efficiency in high-throughput environments. At the same time, improvements in formulation compatibility for colloids including albumin, dextran, gelatins, and hydroxyethyl starch, and for crystalloids such as balanced solutions, dextrose, normal saline, and Ringer's lactate, have reduced barriers to substituting non-PVC containers across diverse clinical applications including blood volume expansion, drug infusion, electrolyte replacement, and nutrient delivery.

Distribution and procurement models are also shifting. Hospital pharmacies continue to be pivotal for acute care supply, yet online pharmacies and wholesale distributors are exerting increasing influence on access and pricing dynamics. Flow technologies-gravity versus infusion pump-are being reconsidered through the lens of compatibility testing and device connectivity. Together, these trends are reshaping supplier strategies, driving consolidation among manufacturers with advanced polymer know-how, and prompting healthcare providers to re-evaluate specifications and supplier risk profiles

Assessment of the cumulative effects of 2025 United States tariffs on supply chains, procurement strategies, and manufacturing responses across the non-PVC IV fluid bags ecosystem

The introduction of United States tariffs in 2025 has produced a cumulative set of effects across sourcing, cost structures, and strategic procurement that ripple through the non-PVC IV fluid bags value chain. Import costs for polymer resins, finished containers, and critical components have risen for organizations dependent on offshore suppliers, prompting buyers and manufacturers to reassess supplier diversification and to accelerate qualification of alternative sources. As a result, nearshoring and regional contract manufacturing options have gained attention as a way to mitigate tariff exposure while maintaining continuity of supply.

Tariff-related cost pressures have also altered negotiation dynamics between manufacturers and distribution channels. Hospital pharmacies and wholesale distributors have sought more transparent pass-through terms and longer contract horizons to stabilize unit costs, while online pharmacies have adapted pricing and fulfillment models to preserve margin. In turn, manufacturers have focused on operational levers-process optimization, economies of scale in non-PVC processing, and incremental automation-to offset tariff-driven input cost increases without compromising product quality or regulatory compliance.

Clinically, procurement constraints influence selection by end users such as ambulatory surgical centers and home healthcare providers, where smaller container sizes and single chamber bags remain prevalent due to handling simplicity. Flow rate considerations are likewise affected, as compatibility testing and device bundling with infusion pumps can add incremental cost and supplier complexity. Ultimately, tariffs have reinforced the strategic importance of resilient supplier networks, flexible manufacturing footprints, and contracting structures that incorporate contingency plans for regulatory and trade volatility

Actionable segmentation insights linking product formulations, clinical applications, end users, packaging formats, container sizes, and flow modalities to commercial strategies

Product type segmentation reveals distinct technical and commercial trajectories for colloids and crystalloids, with colloids encompassing albumin, dextran, gelatins, and hydroxyethyl starch requiring careful consideration of protein stability, osmotic effects, and container-material interactions, while crystalloids such as balanced solutions, dextrose, normal saline, and Ringer's lactate emphasize electrolyte fidelity and container compatibility for extended storage. These formulation differences dictate shelf-life studies, compatibility testing regimes, and clinical positioning strategies, and they drive divergent supplier specialization within the broader materials landscape.

Application-driven insights show that blood volume expansion, drug infusion, electrolyte replacement, and nutrient delivery impose varying demands on delivery accuracy, sterility assurance, and packaging complexity. Products aimed at drug infusion often integrate multi chamber bag architectures to enable co-formulation or staged mixing, whereas electrolyte replacement and simple fluid therapy more commonly utilize single chamber formats that prioritize ease of use and cost-efficiency. End-user segmentation further nuances these choices: hospitals prioritize standardized, high-volume SKUs and rigorous supplier qualification, ambulatory surgical centers and clinics favor ready-to-administer presentations and reduced preparation time, and home healthcare providers require user-friendly formats with clear administration guidance.

Distribution channel segmentation highlights the interplay between hospital pharmacies, online pharmacies, and wholesale distributors in shaping availability and logistics. Hospital pharmacies emphasize traceability and just-in-time delivery capabilities, online pharmacies stress direct-to-patient fulfillment and retail-style convenience, and wholesale distributors focus on scale, aggregation, and last-mile servicing. Packaging segmentation draws attention to single versus multi chamber configurations, with multi chamber bags-dual and triple chamber designs-addressing complex regimens and combination therapies, while container size segmentation spanning up to 250 ml through above 1000 ml reflects procedural and patient population needs. Lastly, flow rate segmentation between gravity flow and infusion pump contexts dictates device compatibility testing, labeling requirements, and clinical training programs, affecting adoption timelines and supplier value propositions

Regional competitive and adoption dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine regulatory approaches, supply models, and clinical uptake

Regional dynamics shape adoption pathways and competitive positioning across the Americas, Europe, Middle East & Africa, and Asia-Pacific, with each geography presenting distinct regulatory frameworks, procurement practices, and clinical preferences. In the Americas, large integrated health systems and centralized purchasing organizations place emphasis on regulatory clarity, supplier reliability, and operational cost containment, driving demand for materials that combine safety credentials with supply-chain transparency. Manufacturers targeting this region need robust quality systems and the ability to support scale at convenient lead times.

In Europe, Middle East & Africa, regulatory heterogeneity and divergent reimbursement models require adaptive go-to-market approaches. Many health systems in this combined region are attentive to sustainability metrics and lifecycle assessments, elevating the importance of demonstrable environmental improvements in non-PVC alternatives. Concurrently, procurement cycles and regional distributors influence inventory strategies and the adoption curve for multi chamber technologies. Asia-Pacific presents a dynamic opportunity with a diverse set of clinical settings ranging from high-volume tertiary centers to decentralized clinics. Rapid adoption in some markets is driven by local manufacturing capacity, cost-sensitive procurement, and rising clinical awareness of safety and performance benefits. Across all regions, distribution channel strength-whether hospital pharmacies, wholesale networks, or online pharmacies-remains a determinant of speed to market and visibility within formularies and clinical pathways

Corporate strategic profiles emphasizing material innovation, manufacturing excellence, channel partnerships, and clinical evidence generation that shape competitive positioning

Company-level dynamics in the non-PVC IV fluid bags space are increasingly defined by technical differentiation, manufacturing footprint, and strategic partnerships. Leading producers are investing in polymer science, compatibility testing, and multi chamber design expertise to broaden their product portfolios and to meet the nuanced needs of various clinical applications. Strategic collaborations with infusion device manufacturers and clinical research partners also strengthen product propositions and facilitate real-world evidence generation that supports formulary inclusion and clinical adoption.

Operational excellence is a distinguishing factor, with companies that have deep process knowledge in non-PVC conversion and sterile filling demonstrating superior cost control and quality consistency. Firms focusing on supply chain resilience are integrating vertical relationships with resin suppliers, securing alternate sourcing lanes, and implementing digital traceability to meet hospital procurement requirements. Distribution strategies vary, with some companies leveraging direct sales and partnerships with hospital group buying organizations, while others prioritize channel relationships with wholesale distributors and e-commerce platforms to reach outpatient and home care segments. Companies that combine robust quality systems, targeted clinical engagement, and flexible manufacturing capacity are best positioned to capture long-term value as healthcare providers update specifications and sustainability goals evolve

Practical and prioritized strategic recommendations for manufacturers and supply chain leaders to accelerate adoption, mitigate tariff risks, and strengthen clinical partnerships

Industry leaders should pursue a coordinated strategy that aligns material innovation, supply chain resilience, and clinical engagement to accelerate adoption of non-PVC IV fluid solutions. First, prioritize investment in polymer research and compatibility testing to ensure performance parity with legacy PVC systems across both colloid and crystalloid formulations, thereby reducing barriers for clinicians and procurement teams. Concurrently, expand validation programs for multi chamber technologies and for container sizes that reflect the needs of acute care, ambulatory settings, and home infusion.

Second, implement a diversified sourcing strategy that reduces exposure to trade disruptions and tariff volatility by qualifying regional manufacturing partners, establishing contingency inventories with trusted wholesale distributors, and exploring nearshoring options where feasible. Third, cultivate deeper relationships with hospital pharmacies, ambulatory surgical centers, and home healthcare providers through targeted clinical education, hands-on demonstrations of handling characteristics, and co-developed protocols that emphasize device compatibility for both gravity flow and infusion pump use. Fourth, integrate sustainability assessments into product development and commercial narratives, documenting lifecycle benefits and waste management improvements to align with purchaser ESG criteria. Finally, leverage strategic partnerships for last-mile distribution and invest in digital traceability and contract-management platforms to streamline procurement and to provide transparency to high-volume buyers

Transparent description of primary and secondary research approaches, stakeholder interviews, and triangulation techniques used to validate insights and segment-level conclusions

The research methodology underpinning this analysis combined primary engagement with key stakeholders and rigorous secondary validation to ensure robust, actionable findings. Primary research included structured interviews with procurement leaders in hospitals, ambulatory surgical centers, clinics, and home healthcare providers, as well as discussions with distribution channel executives representing hospital pharmacies, online pharmacies, and wholesale distributors. These conversations provided direct insight into purchasing criteria, handling preferences, and the operational implications of switching to non-PVC systems.

Secondary research encompassed a comprehensive review of regulatory guidance, material science publications, clinical practice literature, and publicly available company disclosures to frame technology trajectories and confirm manufacturing capabilities. Data triangulation techniques were applied to reconcile perspectives from different stakeholder groups, and methodological rigor was maintained through cross-validation of supplier claims against observed clinical practices and distribution behavior. The segmentation approach was defined to capture product type distinctions between colloids and crystalloids, application-driven requirements such as blood volume expansion and drug infusion, end-user use cases, distribution channel roles, packaging architectures including multi and single chamber bags, container sizes, and flow rate modalities. Limitations include variability in regional regulatory timelines and confidential commercial terms that may affect supplier strategies; nevertheless, the combination of primary insights and secondary corroboration ensures that the conclusions are well-founded and operationally relevant

Conclusive synthesis of the strategic implications, adoption drivers, and practical priorities for stakeholders navigating the non-PVC IV fluid bags transition

The transition to non-PVC IV fluid bags represents a strategically important evolution driven by safety concerns, regulatory expectations, and emerging sustainability priorities. Material innovation and packaging design advances have reduced technical obstacles, enabling broader application across colloid and crystalloid therapies while addressing the needs of diverse end users from hospitals to home healthcare providers. Distribution channels play a central role in adoption velocity, with hospital pharmacies, wholesale distributors, and online pharmacies each shaping access, contract terms, and end-user training requirements.

External forces such as tariff regimes and regional regulatory approaches continue to influence supplier choices and manufacturing footprints, underscoring the need for resilient sourcing strategies and flexible production capabilities. Companies that invest in compatibility testing, multi chamber solutions, and demonstrable lifecycle improvements will be better positioned to meet evolving buyer expectations. For healthcare providers, aligning procurement specifications with clinical performance evidence and total-cost considerations is essential to realize both safety and operational benefits. In closing, the non-PVC IV fluid bag ecosystem is moving toward broader acceptance and integration, but success will depend on coordinated action across product development, clinical validation, and supply chain management

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-PVC IV Fluid Bags Market, by Product Type

  • 8.1. Colloids
    • 8.1.1. Albumin
    • 8.1.2. Dextran
    • 8.1.3. Gelatins
    • 8.1.4. Hydroxyethyl Starch
  • 8.2. Crystalloids
    • 8.2.1. Balanced Solutions
    • 8.2.2. Dextrose
    • 8.2.3. Normal Saline
    • 8.2.4. Ringers Lactate

9. Non-PVC IV Fluid Bags Market, by Packaging

  • 9.1. Multi Chamber Bags
    • 9.1.1. Dual Chamber
    • 9.1.2. Triple Chamber
  • 9.2. Single Chamber Bags

10. Non-PVC IV Fluid Bags Market, by Container Size

  • 10.1. 250-500 Ml
  • 10.2. 500-1000 Ml
  • 10.3. Above 1000 Ml
  • 10.4. Up To 250 Ml

11. Non-PVC IV Fluid Bags Market, by Flow Rate

  • 11.1. Gravity Flow
  • 11.2. Infusion Pump

12. Non-PVC IV Fluid Bags Market, by Application

  • 12.1. Blood Volume Expansion
  • 12.2. Drug Infusion
  • 12.3. Electrolyte Replacement
  • 12.4. Nutrient Delivery

13. Non-PVC IV Fluid Bags Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Clinics
  • 13.3. Home Healthcare Providers
  • 13.4. Hospitals

14. Non-PVC IV Fluid Bags Market, by Distribution Channel

  • 14.1. Hospital Pharmacies
  • 14.2. Online Pharmacies
  • 14.3. Wholesale Distributors

15. Non-PVC IV Fluid Bags Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Non-PVC IV Fluid Bags Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Non-PVC IV Fluid Bags Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Non-PVC IV Fluid Bags Market

19. China Non-PVC IV Fluid Bags Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Angiplast Pvt. Ltd.
  • 20.6. B. Braun Melsungen AG
  • 20.7. Baxter International Inc.
  • 20.8. Fresenius Kabi AG
  • 20.9. Haemotronic SpA
  • 20.10. ICU Medical, Inc.
  • 20.11. JW Life Science Corp.
  • 20.12. Kraton Corporation
  • 20.13. Medline Industries, LP
  • 20.14. Nipro Corporation
  • 20.15. Otsuka Pharmaceutical Factory, Inc.
  • 20.16. PolyCine GmbH
  • 20.17. RENOLIT SE
  • 20.18. Sippex IV bags
  • 20.19. Technoflex SAS

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NON-PVC IV FLUID BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NON-PVC IV FLUID BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES NON-PVC IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA NON-PVC IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY DEXTRAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY DEXTRAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY DEXTRAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY GELATINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY GELATINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY GELATINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY HYDROXYETHYL STARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY HYDROXYETHYL STARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY HYDROXYETHYL STARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY BALANCED SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY BALANCED SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY BALANCED SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY DEXTROSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY DEXTROSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY DEXTROSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY RINGERS LACTATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY RINGERS LACTATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY RINGERS LACTATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY SINGLE CHAMBER BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY SINGLE CHAMBER BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY SINGLE CHAMBER BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY 250-500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY 250-500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY 250-500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY 500-1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY 500-1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY 500-1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY ABOVE 1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY ABOVE 1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY ABOVE 1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY UP TO 250 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY UP TO 250 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY UP TO 250 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY GRAVITY FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY GRAVITY FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY GRAVITY FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY INFUSION PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY INFUSION PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY INFUSION PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY BLOOD VOLUME EXPANSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY BLOOD VOLUME EXPANSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY BLOOD VOLUME EXPANSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY DRUG INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY DRUG INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY DRUG INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY ELECTROLYTE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY ELECTROLYTE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY ELECTROLYTE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY NUTRIENT DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY NUTRIENT DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY NUTRIENT DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY HOME HEALTHCARE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY HOME HEALTHCARE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY HOME HEALTHCARE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS NON-PVC IV FLUID BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE NON-PVC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST NON-PVC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC NON-PVC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN NON-PVC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. GCC NON-PVC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. GCC NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. GCC NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 209. GCC NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 210. GCC NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 211. GCC NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 212. GCC NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. GCC NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. GCC NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. GCC NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION NON-PVC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS NON-PVC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. G7 NON-PVC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. G7 NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 242. G7 NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 243. G7 NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 244. G7 NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 245. G7 NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. G7 NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. G7 NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. G7 NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. NATO NON-PVC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. NATO NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. NATO NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 253. NATO NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 254. NATO NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 255. NATO NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 256. NATO NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. NATO NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. NATO NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. NATO NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL NON-PVC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES NON-PVC IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA NON-PVC IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA NON-PVC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA NON-PVC IV FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA NON-PVC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA NON-PVC IV FLUID BAGS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA NON-PVC IV FLUID BAGS MARKET SIZE, BY MULTI CHAMBER BAGS, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA NON-PVC IV FLUID BAGS MARKET SIZE, BY CONTAINER SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA NON-PVC IV FLUID BAGS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA NON-PVC IV FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA NON-PVC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA NON-PVC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)